Free Trial
NASDAQ:DRRX

DURECT (DRRX) Stock Price, News & Analysis

DURECT logo
$0.67 +0.00 (+0.02%)
As of 07/3/2025 01:00 PM Eastern

About DURECT Stock (NASDAQ:DRRX)

Key Stats

Today's Range
$0.64
$0.70
50-Day Range
$0.50
$0.73
52-Week Range
$0.48
$1.74
Volume
16,699 shs
Average Volume
43,381 shs
Market Capitalization
$20.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

DURECT Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
11th Percentile Overall Score

DRRX MarketRank™: 

DURECT scored higher than 11% of companies evaluated by MarketBeat, and ranked 2683rd out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for DURECT are expected to decrease in the coming year, from ($0.50) to ($0.52) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DURECT is -4.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DURECT is -4.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    DURECT has a P/B Ratio of 2.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about DURECT's valuation and earnings.
  • Percentage of Shares Shorted

    2.90% of the float of DURECT has been sold short.
  • Short Interest Ratio / Days to Cover

    DURECT has a short interest ratio ("days to cover") of 7.5.
  • Change versus previous month

    Short interest in DURECT has recently increased by 2.53%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    DURECT does not currently pay a dividend.

  • Dividend Growth

    DURECT does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.90% of the float of DURECT has been sold short.
  • Short Interest Ratio / Days to Cover

    DURECT has a short interest ratio ("days to cover") of 7.5.
  • Change versus previous month

    Short interest in DURECT has recently increased by 2.53%, indicating that investor sentiment is decreasing.
  • Search Interest

    3 people have searched for DRRX on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added DURECT to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, DURECT insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.20% of the stock of DURECT is held by insiders.

  • Percentage Held by Institutions

    Only 28.03% of the stock of DURECT is held by institutions.

  • Read more about DURECT's insider trading history.
Receive DRRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DURECT and its competitors with MarketBeat's FREE daily newsletter.

DRRX Stock News Headlines

Oppenheimer Sticks to Its Buy Rating for Durect (DRRX)
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

DRRX Stock Analysis - Frequently Asked Questions

DURECT's stock was trading at $0.75 at the start of the year. Since then, DRRX stock has decreased by 11.1% and is now trading at $0.6667.

DURECT Corporation (NASDAQ:DRRX) posted its earnings results on Wednesday, March, 26th. The specialty pharmaceutical company reported ($0.06) EPS for the quarter, missing the consensus estimate of $0.06 by $0.12. The specialty pharmaceutical company had revenue of $2.30 million for the quarter, compared to analyst estimates of $6.91 million. DURECT had a negative trailing twelve-month return on equity of 267.36% and a negative net margin of 91.54%.
Read the conference call transcript
.

DURECT's stock reverse split on Tuesday, December 6th 2022.The 1-10 reverse split was announced on Tuesday, December 6th 2022. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, December 6th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of DRRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DURECT investors own include CymaBay Therapeutics (CBAY), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), GE Aerospace (GE), Catalyst Pharmaceuticals (CPRX) and Pfizer (PFE).

Company Calendar

Last Earnings
3/26/2025
Today
7/03/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:DRRX
Employees
80
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.32 million
Pretax Margin
-305.34%

Debt

Sales & Book Value

Annual Sales
$2.03 million
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
2.30

Miscellaneous

Free Float
30,049,000
Market Cap
$20.69 million
Optionable
Optionable
Beta
0.64
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:DRRX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners